321 related articles for article (PubMed ID: 33538254)
21. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
[TBL] [Abstract][Full Text] [Related]
22. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
[TBL] [Abstract][Full Text] [Related]
23. N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).
Astor BC; Yi S; Hiremath L; Corbin T; Pogue V; Wilkening B; Peterson G; Lewis J; Lash JP; Van Lente F; Gassman J; Wang X; Bakris G; Appel LJ; Contreras G
Circulation; 2008 Apr; 117(13):1685-92. PubMed ID: 18362234
[TBL] [Abstract][Full Text] [Related]
24. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
Eggers KM; Venge P; Lind L
Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
[TBL] [Abstract][Full Text] [Related]
25. N-terminal prohormone B-type natriuretic peptide and cardiovascular function in Africans and Caucasians: the SAfrEIC study.
Kruger R; Schutte R; Huisman HW; Hindersson P; Olsen MH; Schutte AE
Heart Lung Circ; 2012 Feb; 21(2):88-95. PubMed ID: 22119736
[TBL] [Abstract][Full Text] [Related]
26. Association of N-Terminal Pro B-Type Natriuretic Peptide With Blood Pressure and Pulse Pressure in Elderly People - A Cross-Sectional Population Study.
Sasaki N; Yamamoto H; Ozono R; Fujiwara S; Kihara Y
Circ J; 2018 Jul; 82(8):2049-2054. PubMed ID: 29794411
[TBL] [Abstract][Full Text] [Related]
27. Socioeconomic position is associated with N-terminal pro-brain natriuretic peptide (NT-proBNP)-Results of the population-based Heinz Nixdorf Recall study.
Rudman M; Frank M; Emmel C; Matusch E; Kara K; Mahabadi AA; Erbel R; Jöckel KH; Dragano N; Schmidt B
PLoS One; 2021; 16(8):e0255786. PubMed ID: 34415953
[TBL] [Abstract][Full Text] [Related]
28. Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.
van Peet PG; de Craen AJ; Gussekloo J; de Ruijter W
Age (Dordr); 2014 Jun; 36(3):9660. PubMed ID: 24807464
[TBL] [Abstract][Full Text] [Related]
29. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events - The Japan Morning Surge-Home Blood Pressure Study.
Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
[TBL] [Abstract][Full Text] [Related]
30. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
[TBL] [Abstract][Full Text] [Related]
31. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
[TBL] [Abstract][Full Text] [Related]
32. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
33. Association between N-terminal pro B-type natriuretic peptide and day-to-day blood pressure and heart rate variability in a general population: the Ohasama study.
Satoh M; Hosaka M; Asayama K; Kikuya M; Inoue R; Metoki H; Tsubota-Utsugi M; Hara A; Hirose T; Obara T; Totsune K; Hoshi H; Mano N; Node K; Imai Y; Ohkubo T
J Hypertens; 2015 Aug; 33(8):1536-41. PubMed ID: 25827428
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Everett BM; Ridker PM; Cook NR; Pradhan AD
Am J Cardiol; 2015 Aug; 116(4):532-7. PubMed ID: 26081066
[TBL] [Abstract][Full Text] [Related]
35. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.
Yano Y; Reis JP; Colangelo LA; Shimbo D; Viera AJ; Allen NB; Gidding SS; Bress AP; Greenland P; Muntner P; Lloyd-Jones DM
JAMA; 2018 Nov; 320(17):1774-1782. PubMed ID: 30398601
[TBL] [Abstract][Full Text] [Related]
36. Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis.
Sanchez OA; Jacobs DR; Bahrami H; Peralta CA; Daniels LB; Lima JA; Maisel A; Duprez DA
J Hypertens; 2015 May; 33(5):966-74. PubMed ID: 25909698
[TBL] [Abstract][Full Text] [Related]
37. Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.
Patel N; Gutiérrez OM; Arora G; Howard G; Howard VJ; Judd SE; Prabhu SD; Levitan EB; Cushman M; Arora P
Int J Cardiol; 2019 Jul; 286():145-151. PubMed ID: 30878238
[TBL] [Abstract][Full Text] [Related]
38. Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Yano Y; Reis JP; Tedla YG; Goff DC; Jacobs DR; Sidney S; Ning H; Liu K; Greenland P; Lloyd-Jones DM
JAMA Cardiol; 2017 Apr; 2(4):381-389. PubMed ID: 28199497
[TBL] [Abstract][Full Text] [Related]
39. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
[TBL] [Abstract][Full Text] [Related]
40. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study.
Al Rifai M; Taffet GE; Matsushita K; Virani SS; De Lemos J; Khera A; Berry J; Ndumele C; Aguilar D; Sun C; Hoogeveen RC; Selvin E; Ballantyne CM; Nambi V
Am J Cardiol; 2023 Oct; 204():295-301. PubMed ID: 37567021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
